SomaLogic announced their collaboration with Citogen, the Longwood Group’s customer services and support unit, to establish the company’s first authorized site in Spain. As part of the agreement, Citogen will offer the 7,000-plex SomaScan Assay and provide SomaScan data to their customers in Southern Europe supporting biological research across an array of disciplines including clinical research, population health studies and nutrigenomics.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SLGC:
- SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe
- SomaLogic Announces Chief Financial Officer Transition
- SomaLogic to Participate in the Jefferies Healthcare Conference
- SomaLogic expands into China with groundbreaking Biostar Technology Limited Partnership
- SomaLogic opens their first-ever proteomics grant program to APAC life sciences researchers